This announcement is a separate document:
维康药业：浙江维康药业股份有限公司全资子公司浙江维康医药商业有限公司拟转让持有的浙江维康医药零售有限公司全部股权涉及其股东全部权益评估项目资产评估报告
Zhejiang Wecome Pharmaceutical: Zhejiang Wecome Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Zhejiang Wecome Pharmaceutical Co., Ltd., intends to transfer all its equity holdings in Zhejiang Wecome Pharmaceutical Retail Co., Ltd., which involves the evaluation project of all the equity interests of its shareholders and assets evaluation report.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.